Preliminary results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee using ActiPatch Therapy have been announced.
BioElectronics Corporation says the initial interim analysis showed statistically significant results for the primary and secondary outcomes measures. The study is being led by Doctor Gianluca Bagnato, Division of Rheumatology, University Hospital Gaetano Martino, Messina, Italy. The final analysis of the full study data set will be carried out soon and the results have been accepted in the Annals of the Rheumatic Diseases and presented at the European League against Rheumatism 2014 conference.
"The completion of these randomized, placebo controlled trials, on pain resulting from three very distinct musculoskeletal pathophysiological processes, is highly significant," commented Andrew Whelan, BioElectronics CEO. "The data from these high quality clinical trials will be available before the FDA's May 21st deadline for comments on proposed reclassification of our devices to Class II. This schedule will allow us to submit the 510K application without any delay once the final ruling is made by the FDA."
BioElectronics is conducting a series of clinical research studies using its medical devices for other musculoskeletal pain conditions that include, acute nonspecific lower back pain, as well as the surgical indications of postoperative recovery for 3rd molar extraction and hernia repair.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- The Genetic History Of Ice Age Europe
- Exodus 2100: Due To Climate Change
- What Lies Beneath West Antarctica?
- Professor Frenkel: Why Shouldn't We Drop Algebra From Our Education System?
- Scientists Discover Oral Sex In Spiders
- Matter Can Potentially Accelerate The Expansion Of The Universe
- The Number Of My Publications Has Four Digits
- "actually I prefer something real, not paper printed by a private entity, backed by full faith and..."
- "Hello Peter:I presume my readers are busy. I presume they have a mild degree of experience about..."
- "So keep your cash an watch the world come to an end . Cheap and selfish is the right way ..."
- "There is a tendency to label some as Global Warming Alarmists I think the warnings have been conservative..."
- "The guardian? You're funny :-) The CESM models only prove accurate with post-hoc data input corrections..."
- 3 Reasons Aerial Pesticides Are Not Causing Autism
- Most Stores Refuse E-Cigarette Sales to Minors
- Vitamin C Conundrum for the Organic Crowd
- Newsweek Journalist Loses His Mind, Time-Traveling Radioactivity And More Media Links
- This Single-Celled Organism Is Capable Of Learning
- Study Says Bilingual Kids’ Brains Are Smarter & Faster
- UC San Diego bioengineers create first online search engine for functional genomics data
- UK Health Check has only modest impact on risk factors for cardiovascular disease
- Adult brain prunes branched connections of new neurons
- Five new breast cancer genes and range of mutations pave way for personalized treatment
- Quantum sensors for high-precision magnetometry of superconductors